Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Ovarian Neoplasms 32Testicular Neoplasms 13Carcinoma, Ovarian Epithelial 9Testicular Germ Cell Tumor 7Teratoma 7Ovarian Germ Cell Cancer 7Sarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Central Nervous System Neoplasms 4Osteosarcoma 3Neoplasms 3Lung Neoplasms 3Fallopian Tube Neoplasms 3Endodermal Sinus Tumor 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Uterine Cervical Neoplasms 2Seminoma 2Recurrence 2Optic Nerve Glioma 2Neuroblastoma 2Melanoma 2Medulloblastoma 2Gestational Trophoblastic Disease 2Drug-Related Side Effects and Adverse Reactions 2Desmoplastic Small Round Cell Tumor 2Chondrosarcoma 2Carcinoma, Embryonal 2Brenner Tumor 2Breast Neoplasms 2

Interventions

utomilumab 1tislelizumab 1spartalizumab 1entinostat 1cemiplimab 1Thrombopoietin 1Polyethylene Glycols 1Nivolumab 1Immunologic Techniques 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cyclophosphamide 1Carboplatin 1Bevacizumab 1ADI PEG20 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uveal Melanoma × Etoposide × Gynecologic × Clear all
NCT00003597 2014-07-24

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Children's Oncology Group

Phase 1 Completed
16 enrolled
CNSClassical hematologyDermatologicGenitourinaryGynecologicOther solid neoplasmSarcoma

Uveal Melanoma, Astrocytoma, Carcinoma, Renal Cell, Medulloblastoma, Melanoma, Neoplasms, Wilms Tumor, Neuroblastoma, Neutropenia, Retinoblastoma, Osteosarcoma, Testicular Neoplasms, Thrombocytopenia, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡